Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000032015 | SCV000486509 | likely pathogenic | Biotinidase deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000032015 | SCV001581354 | pathogenic | Biotinidase deficiency | 2023-07-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp386*) in the BTD gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 158 amino acid(s) of the BTD protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with biotinidase deficiency (PMID: 10400129, 27657684). ClinVar contains an entry for this variant (Variation ID: 38569). This variant disrupts a region of the BTD protein in which other variant(s) (p.Leu498Phefs*13) have been determined to be pathogenic (PMID: 17382128, 19728141, 29359854). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000032015 | SCV004211467 | pathogenic | Biotinidase deficiency | 2023-04-16 | criteria provided, single submitter | clinical testing |